Baseline characteristics associated with early visual acuity gains after ranibizumab treatment for retinal vein occlusion

BACKGROUND: To identify baseline patient characteristics associated with early clinically significant visual acuity (VA) improvements within 3 months of treatment initiation in ranibizumab-treated patients with retinal vein occlusion (RVO) in the SHORE study. METHODS: Post hoc analysis of baseline p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lloyd Clark, W., Liu, Mimi, Kitchens, John, Wang, Pin-wen, Haskova, Zdenka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325686/
https://www.ncbi.nlm.nih.gov/pubmed/30621653
http://dx.doi.org/10.1186/s12886-018-1012-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325686/
https://www.ncbi.nlm.nih.gov/pubmed/30621653
http://dx.doi.org/10.1186/s12886-018-1012-y

Ejemplares similares